+91- 99099 19545
info@accuprec.com
Patrice Cani, professor at UCLouvain, and his team conducted the first pilot study in humans to observe the impact of the bacteria Akkermansia (ingestion for 3 months), particularly on the reduction of cardiovascular risk factors. The results are published in...
Read More
Sun Pharma Advanced Research Company Ltd. (SPARC) has announced that the U.S. Food and Drug Administration (USFDA) has accepted for review SPARC’s New Drug Application (NDA) for Taclantis (Paclitaxel Injection Concentrate for Suspension). The NDA filing is based on successful...
Read More
Ministry of AYUSH (MOA) and Ministry of Electronics and Information Technology (MeitY) have signed MOU at New Delhi today for collaborating with each other for digitization of AYUSH Sector. MeitY has agreed to advise and give technical support to MOA...
Read More
Delhi Pharmaceuticals Sciences and Research University (DPSRU) organized “Hands on training on microfluidizer and its role in development of Nanodelivery systems” was held on 27th June 2019 at 10:00 am at board room. The event was started with felicitation of...
Read More The recent study on “Size, composition and distribution of human resource for health in India: new estimates using National Sample Survey and Registry data” carried out by the researchers from the Indian Institute of Public Health, Gurugram has revealed that...
Read More Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is a centrally sponsored scheme. The ratio of contribution towards premium between Centre and State is 60:40 in all States except North Eastern States and the three Himalayan States, where the...
Read More Public health and hospitals being a State subject, it is the responsibility of the States/UTs to regularly scrutinize the functioning of all healthcare facilities including Government hospitals and Community Health Centres (CHCs) to ensure their proper functioning. However, under National...
Read More Union Minister of Skill Development and Entrepreneurship Dr. Mahendra Nath Pandey said that India would be needing more than 70 lakh skilled manpower in coming months due to unleashing of economy. He said, more than 62 percent of India’s population...
Read More Dr. Reddy’s Laboratories Ltd. has announced launch of an over-the-counter (OTC) store-brand equivalent of Mucinex® D Extended Release Tablets in two strengths— Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg—in the...
Read More The global AI in healthcare market is expected to reach over 8 USD billion by 2026 and is expected to grow at CAGR 49.7% during the forecast period, 2019-2026. An innovation like Artificial Intelligence could have far-reaching effects on healthcare...
Read More Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited have announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodium glucose co-transporter-2 (SGLT2) inhibitor, Remogliflozin Etabonate (Remogliflozin) in India. Under the terms of the agreement, Glenmark will receive...
Read More Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400mg (base).Lupin’s alliance partner Natco had received an approval from the United States Food and Drug Administration (U.S. FDA) earlier. Lupin’s Imatinib Mesylate Tablets, 100mg (base)...
Read More
Two members from UK delegation - Mark Pollack and Nigel Silcox visited Accuprec Research Labs Pvt. Ltd. They visited and observed the facilities available in the Contract Research Organisation (CRO). They received information about services provided by Accuprec. Dr. Rina...
Read More
“Let us work towards not losing any pregnant woman and child to preventable causes”. This was stated by Dr Harsh Vardhan, Union Minister of Health and Family Welfare atthe inauguration of National Workshop on International Conference on Population and Development...
Read More One of India’s leading pharmaceutical companies, Intas Pharmaceuticals takes a revolutionary step towards making therapy for chronic immune thrombocytopenia (ITP) more accessible to patients by being the first to launch Romiplostim in India under the name Romy. Romiplostim is one...
Read More
Accuprec Research Labs Pvt. Ltd. © 2024
